BNGO/ News und Infos Forum: Community User: Ray7

Oppenheimer analyst hebt rating von 1,50 auf 15$ Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer Oppenheimer analyst Kevin DeGeeter raised the firm's price target on Bionano Genomics to $15 from $1.50 and keeps an Outperform rating on the shares. The analyst cites substantial balance sheet expansion through $380M-plus in equity issuance; and plans for next-generation optical imaging platform with potential for $100 genome. While his forecast continues to be driven by adoption of optical imaging for cytogenetics, newly planned studies in prenatal/pediatric populations should expand the addressable market, while COGs as low as $100 per consumable on next-generation platform offers potential for deeper market penetration. Read more at: https://thefly.com/n.php?id=3242722

https://ir.bionanogenomics.com/single-news-releases/?storyid=7613548805073024 ...

Bngo in Harvard https://www.dfhcc.harvard.edu/events/detail/event/molecular-genetics-core-facility-bionano-saphyr-optical-genome-mapping-to-identify-pathogenic-st/

Oh falsches Forum. Bin in News sorry

Hier mal die Aktualisierung, brauchen wir aber nicht. Haben ja Perstoper https://stockinvest.us/stock/BNGO

Financial outlook for BNGO stock in 2021 and beyond Firstly, the revenue outlook for 2021 looks positive according to analyst forecasts. Currently, the average revenue forecast for 2021 is sitting at $18.5 million. This suggests a YOY growth in revenue of 136% according to Yahoo Finance data. However, the recent performance in the Q3 2020 earnings results was underwhelming. The total revenue for the quarter was $2.2 million, a decrease of 33.7% compared to the same period in 2019. BioNano noted the decrease is “largely driven by customers temporarily shutting down their lab operations in response to the COVID-19 pandemic.” It’s clear with analysts suggesting strong revenue growth in 2021, the improving COVID restrictions should play a positive role.

Die Punkte sollten you. Tube sein

The recorded presentations of all speakers can be viewed on bionanogenomics.com at https://bionanogenomics.com/library/videos/ and on Bionano’s *** page at https://www.***.com/c/bionanogenomics.

Mögliche +587% in den nächsten 3 Monaten. https://stockinvest.us/stock/BNGO

http://www.globenewswire.com/news-release/2021/02/02/2168140/0/en/Saphyr-Study-Is-First-to-Analyze-Cancer-Regulation-at-Level-of-Single-DNA-Molecules-Opens-Promising-New-Avenue-of-Cancer-Research.html

Saphyr Study Is First to Analyze Cancer Regulation at Level of Single DNA Molecules, Opens Promising New Avenue of Cancer Research globenewswire | 02.02.2021 | 14:00 Publication on novel Saphyr based method to analyze DNA methylation in cancer genomes enables new field of cancer research and drug target discovery

https://twitter.com/bionanogenomics/status/1356293237963710471?s=19